Literature DB >> 17086358

Inhibition of adhesion and proliferation of peritoneally disseminated tumor cells by pegylated catalase.

Kenji Hyoudou1, Makiya Nishikawa, Yuki Kobayashi, Yukari Kuramoto, Fumiyoshi Yamashita, Mitsuru Hashida.   

Abstract

Hydrogen peroxide may aggravate the peritoneal dissemination of tumor cells by activating the expression of a variety of genes. In this study, we used pegylated catalase (PEG-catalase) to examine whether prolonged retention of catalase activity within the peritoneal cavity is effective in inhibiting peritoneal dissemination in mouse models. Murine B16-BL6 cells or colon 26 cells labeled with firefly luciferase gene were inoculated intraperitoneally into syngeneic mice. Compared with unmodified catalase, PEG-catalase was retained in the peritoneal cavity for a long period after intraperitoneal injection. A single injection of PEG-catalase just before tumor inoculation significantly reduced the number of the tumor cells at 1 and 7 days. The changes in the expression of molecules involved in the metastasis were evaluated by real time quantitative PCR analysis. Inoculation of the tumor cells increased the expression of intercellular adhesion molecule (ICAM)-1 in the greater omentum, which was inhibited by PEG-catalase. An injection of PEG-catalase at 3 days after tumor inoculation also reduced the number of the tumor cells, suggesting that processes other than the adhesion of tumor cells to peritoneal organs are also inhibited. Daily doses of PEG-catalase significantly prolonged the survival time of tumor-bearing mice. These results indicate that intraperitoneal injection of PEG-catalase inhibits the multiple processes of peritoneal dissemination of tumor cells by scavenging hydrogen peroxide in the peritoneal cavity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086358     DOI: 10.1007/s10585-006-9036-8

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  37 in total

1.  Red blood cells inhibit tumour cell adhesion to the peritoneum.

Authors:  M E van Rossen; M P Stoop; L J Hofland; P M van Koetsveld; F Bonthuis; J Jeekel; R L Marquet; C H van Eijck
Journal:  Br J Surg       Date:  1999-04       Impact factor: 6.939

2.  Scavenging of reactive oxygen species leads to diminished peritoneal tumor recurrence.

Authors:  M E van Rossen; W Sluiter; F Bonthuis; H Jeekel; R L Marquet; C H van Eijck
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

3.  Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer.

Authors:  Akihiro Sako; Joji Kitayama; Hiroyuki Koyama; Hikaru Ueno; Hiroaki Uchida; Hirofumi Hamada; Hirokazu Nagawa
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

4.  Role of milky spots as selective implantation sites for malignant cells in peritoneal dissemination in mice.

Authors:  H Tsujimoto; A Hagiwara; M Shimotsuma; C Sakakura; K Osaki; S Sasaki; T Ohyama; M Ohgaki; T Imanishi; J Yamazaki; T Takahashi
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.

Authors:  Y Yabe; M Nishikawa; A Tamada; Y Takakura; M Hashida
Journal:  J Pharmacol Exp Ther       Date:  1999-05       Impact factor: 4.030

6.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

7.  Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure.

Authors:  A Belkhiri; C Richards; M Whaley; S A McQueen; F W Orr
Journal:  Lab Invest       Date:  1997-11       Impact factor: 5.662

8.  Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation.

Authors:  E N Baramova; K Bajou; A Remacle; C L'Hoir; H W Krell; U H Weidle; A Noel; J M Foidart
Journal:  FEBS Lett       Date:  1997-03-24       Impact factor: 4.124

9.  Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding.

Authors:  S Fujimoto; R D Shrestha; M Kokubun; M Ohta; M Takahashi; K Kobayashi; S Kiuchi; K Okui; T Miyoshi; N Arimizu
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

10.  Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination.

Authors:  Y Yonemura; T Fujimura; S Fushida; S Takegawa; T Kamata; K Katayama; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  World J Surg       Date:  1991 Jul-Aug       Impact factor: 3.352

View more
  3 in total

1.  SOD derivatives prevent metastatic tumor growth aggravated by tumor removal.

Authors:  Kenji Hyoudou; Makiya Nishikawa; Yuki Kobayashi; Mai Ikemura; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Clin Exp Metastasis       Date:  2008-03-21       Impact factor: 5.150

2.  Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer.

Authors:  Wei Li; Zhenhua Ma; Jiguang Ma; Xuqi Li; Qinhong Xu; Wanxing Duan; Xin Chen; Yunfu Lv; Shuang Zhou; Erxi Wu; Qingyong Ma; Xiongwei Huo
Journal:  Oncotarget       Date:  2015-10-13

3.  Evaluation of transgene expression characteristics and DNA vaccination against melanoma metastasis of an intravenously injected ternary complex with biodegradable dendrigraft poly-L-lysine in mice.

Authors:  Yukinobu Kodama; Ayako Tokunaga; Junya Hashizume; Hiroo Nakagawa; Hitomi Harasawa; Tomoaki Kurosaki; Tadahiro Nakamura; Koyo Nishida; Mikiro Nakashima; Mitsuru Hashida; Shigeru Kawakami; Hitoshi Sasaki
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.